These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20229796)

  • 21. [Systemic HIV-non-Hodgkin lymphoma in the era of HAART. Natural history].
    Juzbasic S; Spina M; Vaccher E; Tirelli U
    Recenti Prog Med; 2001 Nov; 92(11):676-89. PubMed ID: 11765662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changing pattern of primary cerebral lymphoma in the highly active antiretroviral therapy era.
    Cingolani A; Fratino L; Scoppettuolo G; Antinori A
    J Neurovirol; 2005; 11 Suppl 3():38-44. PubMed ID: 16540454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful administration of aggressive chemotherapy concomitant to tuberculostatic and highly active antiretroviral therapy in a patient with AIDS-related Burkitt's lymphoma.
    Lehmann C; Wyen C; Hoffmann C; Fätkenheuer G
    HIV Med; 2005 Jan; 6(1):51-3. PubMed ID: 15670254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Non-Hodgkin's lymphomas of the digestive tract and anexal glands in AIDS patients].
    Corti M; Villafañe Fioti MF; Lewi D; Schtirbu R; Narbaitz M; de Dios Soler M
    Acta Gastroenterol Latinoam; 2006 Dec; 36(4):190-6. PubMed ID: 17225446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved survival and chemotherapy response among patients with AIDS-related non-Hodgkin's lymphoma receiving highly active antiretroviral therapy.
    Diamond C; Taylor TH; Im T; Miradi M; Anton-Culver H
    Hematol Oncol; 2006 Sep; 24(3):139-45. PubMed ID: 16604565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy.
    Lim ST; Karim R; Tulpule A; Nathwani BN; Levine AM
    J Clin Oncol; 2005 Nov; 23(33):8477-82. PubMed ID: 16230675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
    Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
    Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decrease in the frequency of meningeal involvement in AIDS-related systemic lymphoma in patients receiving HAART.
    Navarro JT; Vall-Llovera F; Mate JL; Morgades M; Feliu E; Ribera JM
    Haematologica; 2008 Jan; 93(1):149-50. PubMed ID: 18166804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serbian lymphoma study group (SLG): the prognosis of AIDS-related non-Hodgkin's lymphoma.
    Djunic I; Jevtovic DL; Ranin J; Salemovic D; Tomin D; Mihaljevic B
    Biomed Pharmacother; 2008 Jan; 62(1):12-5. PubMed ID: 17629445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human immunodeficiency virus-associated lymphoma.
    Parekh S; Ratech H; Sparano JA
    Clin Adv Hematol Oncol; 2003 May; 1(5):295-301. PubMed ID: 16224426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS.
    Boulanger E; Gérard L; Gabarre J; Molina JM; Rapp C; Abino JF; Cadranel J; Chevret S; Oksenhendler E
    J Clin Oncol; 2005 Jul; 23(19):4372-80. PubMed ID: 15994147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modern management of non-Hodgkin lymphoma in HIV-infected patients.
    Mounier N; Spina M; Gisselbrecht C
    Br J Haematol; 2007 Mar; 136(5):685-98. PubMed ID: 17229246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignancies in HIV: the Indian scenario.
    Dhir AA; Sawant SP
    Curr Opin Oncol; 2008 Sep; 20(5):517-21. PubMed ID: 19106653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV infection and cancer in the era of highly active antiretroviral therapy (Review).
    Barbaro G; Barbarini G
    Oncol Rep; 2007 May; 17(5):1121-6. PubMed ID: 17390054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of HAART on AIDS-related Kaposi's sarcoma and non-Hodgkin's lymphoma.
    Clayton G; Omasta-Martin A; Bower M
    J HIV Ther; 2006 Sep; 11(3):51-3. PubMed ID: 17580498
    [No Abstract]   [Full Text] [Related]  

  • 36. AIDS related systemic non-Hodgkin's lymphoma.
    Powles T; Matthews G; Bower M
    Sex Transm Infect; 2000 Oct; 76(5):335-41. PubMed ID: 11141847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AIDS and cancer in the era of highly active antiretroviral therapy (HAART).
    Rabkin CS
    Eur J Cancer; 2001 Jul; 37(10):1316-9. PubMed ID: 11423263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical aspects and management of AIDS-related lymphoma.
    Sparano JA
    Eur J Cancer; 2001 Jul; 37(10):1296-305. PubMed ID: 11423261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biology and management of AIDS-associated non-Hodgkin's lymphoma.
    Gates AE; Kaplan LD
    Hematol Oncol Clin North Am; 2003 Jun; 17(3):821-41. PubMed ID: 12852657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the tumor microenvironment in HIV-associated lymphomas.
    Taylor JG; Liapis K; Gribben JG
    Biomark Med; 2015; 9(5):473-82. PubMed ID: 25985176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.